34.61
+5.01%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Phibro Animal Health
From its filings with the US Securities and Exchange Commission
Phibro Animal Health is based in Teaneck, New Jersey and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker PAHC. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 30 June 2026, it reported revenue of $1.52bn and net income of $99.7m. At that date it held total assets of $1.50bn and shareholders' equity of $385.5m.
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, cattle and swine producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.
We have focused our efforts in regions where the majority of livestock production is consolidated in large commercial farms. We believe we are well positioned to grow our sales with our established network of sales, marketing and distribution professionals in markets in North America, Latin America, Asia Pacific, Europe, Africa and the Middle East.
Quoted from its 10-K, filed 26 Aug 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 11 Apr 2014
- Employees
- 2,475
- Website
- pahc.com ↗
- Head office
- GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Jack BendheimChairman of the Board, President, Chief Executive Officer, since 1984$5.3m
- Mr. Glenn DavidChief Financial Officer$1.3m
- Mr. Larry MillerChief Operating Officer$2.4m
- Mr. Daniel BendheimExecutive Vice President - Corporate Strategy, Director, since 2013$1.1m
- Ms. Judith WeinsteinSenior Vice President, General Counsel, Corporate Secretary$1.0m
- Ms. Lisa EscuderoSenior Vice President - Human Resources
- Mr. Jonathan BendheimSenior Vice President - Global Technology and Talent, Director, since 2024
- Mr. Anthony AndolinoVice President - Finance, Treasurer
- Mr. Alejandro BernalIndependent Director$50,000
- Mr. E. CorcoranIndependent Director$50,000
- Mr. Sam GejdensonIndependent Director$60,000
- Ms. Joyce LeeIndependent Director$20,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 40
- Environment
- 42
- Social
- 67
- Governance
- 12
- Direct emissions (scope 1)
- 31,330 t
- Energy emissions (scope 2)
- 17,272 t
- Women in the workforce
- 33%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Phibro Animal Health Corp has several notable strengths that contribute to its competitive advantage in the market:
Weaknesses
- Despite its strengths, Phibro Animal Health Corp also faces certain weaknesses that may impede its growth and market performance:
Opportunities
- Phibro Animal Health Corp can leverage the following opportunities to further expand its market position and profitability:
Threats
- Phibro Animal Health Corp faces certain threats that could potentially hinder its performance and competitive position:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.